Prosecution Insights
Last updated: April 19, 2026

Minerva Biotechnologies Corporation

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19098785 ANTI-MUC1* ANTIBODY DRUG COMPLEXES AND USES THEREOF HUYNH, PHUONG N 1641 Non-Final OA Apr 02, 2025
14596051 METHOD FOR INDUCING CELLS TO LESS MATURE STATE NGUYEN, QUANG 1631 Non-Final OA Jan 13, 2015

Managing Minerva Biotechnologies Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month